Sanofi chief defends cancer drug Zaltrap; FDA unveils a litany of problems at NECC;

@FiercePharma: Pfizer won't report earnings on Tuesday as planned, thanks to Hurricane Sandy. More | Follow @FiercePharma

> Sanofi ($SNY) CEO Christopher Viebacher argued against the Memorial Sloan-Kettering doctors who weighed in against using the colorectal cancer treatment Zaltrap. Report

> The FDA released disturbing details of unsanitary conditions at the compounding pharmacy implicated in a deadly meningitis outbreak. Report

> France's Ipsen raised its outlook for the year after posting a 5% increase in third-quarter revenue on strong sales of specialty drugs. Report

> Chinese officials say they are considering plans to push merger activity in the pharmaceutical sector. Report

> Abbott Laboratories ($ABT) said it would tender for as much as $7.7 billion in bonds as it raises $16 billion in debt for its split into two companies. Report

> India's Sun Pharmaceutical is waiting for FDA approval for its version of Doxil, the Johnson & Johnson ($JNJ) cancer drug whose supplies are now being restored. Report

Medical Device News

 @FierceMedDev: Hospira faces a Class I recall for its Symbiq infusion system. More | Follow @FierceMedDev

 @MarkHFierce: Drug eluting stents have benefits in people over age 80, acc. to the XIMA study. More | Follow @MarkHFierce

 @DamianFierce: Patheon is spending $255M on softgel specialist Banner Pharmacap. More | Follow @DamianFierce

> Abbott launches massive bond issue to fuel split. Item

> Verax raises $3.3M for blood Dx. News

Biotech News

 @FierceBiotech: Human heart simulated on world's fastest supercomputer. More | Follow @FierceBiotech

 @JohnCFierce: Survey: Many docs will be slow to switch to biosimilar mAbs. More | Follow @JohnCFierce

 @RyanMFierce: Five3, maker of cancer genomics software, takes off from UCSC labs. More | Follow @RyanMFierce

> Principia platform earns $12.5M tranche from A-list venture players. News

> GSK antes up Viiv stake, grabs control of potential HIV blockbuster. Story

CRO News

> Patheon buys softgel specialist for $255M. Item

> Small CROs band together to better compete. Story

> Clinipace raises $9M to staff up after acquisition. Article

> Quintiles eyes first global trial for Indonesia. News

Biotech IT News

> Five3, maker of cancer genomics software, takes off from UCSC labs. News

> Human heart simulated on world's fastest supercomputer. Article

> Swedish bioinformatics group grabs $840K to fuel growth, report says. Story

> Accelrys acquisition hunt continues with $30M Aegis deal. Item

And Finally... It's not unprecedented for CEOs to exhort their employees to vote Republican; it was a Big Pharma tactic in 2000, Forbes reports. Report


Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.